NR4A1 and diabetes mellitus: The dysregulation of these genes can lead to cardiovascular disease,28 cancer29 and diabetes.30 Research on NRs began in the mid-1980s when molecular cloning of several hormone receptors revealed their common structural framework.31 As a consequence of their central role in governing cell fate, NRs constitute targets for 15–20% of all pharmacologic drugs.32,33